Search results for MEK1

Anti-MEK1 (phospho T292) antibody [EPR2365Y], Abcam, AB76314

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-MEK1 (phospho T386) antibody [8HCLC], Abcam, AB277789

What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies .

Anti-Phospho-MAP2K1/MEK1 (S298) Antibody (R2C20), AntibodySystem, RHF95504

Anti-Phospho-MAP2K1/MEK1 (T292) Antibody (R2C21), AntibodySystem, RHF95505

Anti-Phospho-MAP2K1/MEK1 (Ser298) Antibody (R2C22), AntibodySystem, RHF95506

Anti-Phospho-MAP2K1/MEK1 (Thr292) Antibody (R2C23), AntibodySystem, RHF95507

PE Anti-MEK1 (phospho S298) antibody [EPR3338], Abcam, AB306197

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Phospho-MEK1/2(Ser217/221) Antibody (YA5835), MedChemexpress, HY-P86143

Phospho-MEK1/2(Ser217/221) Antibody (YA5835) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-MEK1/2(Ser217/221).

APC Anti-MEK1 (phospho S298) antibody [EPR3338], Abcam, AB306198

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Smek Homolog 2, Suppressor Of Mek1 (Dictyostelium) Antibody, Abbexa, abx115622

Smek Homolog 2, Suppressor Of Mek1 (Dictyostelium) Antibody is a Rabbit Polyclonal antibody against Smek Homolog 2, Suppressor Of Mek1 (Dictyostelium).